Ian Maidment Selected Research

Ian Maidment Research Topics

10	Dementia (Dementias) 01/2021 - 01/2008
5	Cognitive Dysfunction 01/2022 - 01/2009
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2008
2	Pain (Aches) 12/2023 - 01/2022
2	Intellectual Disability (Idiocy) 12/2023 - 01/2023
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 03/2018
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2018 - 01/2016
2	Delirium 09/2014 - 01/2009
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2023
1	Social Phobia 12/2023
1	Neurodevelopmental Disorders 12/2023
1	Epilepsy (Aura) 12/2023
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	COVID-19 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Necrosis 01/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Infections 11/2020
1	Venous Thromboembolism 11/2020
1	Stroke (Strokes) 11/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2020
1	Atrophy 01/2020
1	Feeding and Eating Disorders (Eating Disorder) 06/2018
1	Parkinson Disease (Parkinson's Disease) 03/2012
1	Lewy Body Disease (Lewy Body Dementia) 03/2012

7	BenzodiazepinesIBA 01/2022 - 01/2019
7	Cholinergic Antagonists (Anticholinergics)IBA 01/2022 - 01/2009
3	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2016
2	Zolpidem (Ambien)FDA LinkGeneric 01/2021 - 11/2020
2	zopiclone (Zop)IBA 01/2021 - 11/2020
2	zaleplon (Sonata)FDA LinkGeneric 01/2021 - 11/2020
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2012 - 01/2008
1	Dronabinol (THC)FDA LinkGeneric 12/2023
1	CannabidiolIBA 12/2023
1	Medical MarijuanaIBA 12/2023
1	C-Reactive ProteinIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Histamine Antagonists (Antihistamines)IBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 01/2021
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2021
1	TabletsIBA 09/2020
1	Antidepressive Agents (Antidepressants)IBA 04/2018
1	Gastrointestinal AgentsIBA 04/2018
1	Antiparkinson Agents (Antiparkinsonian Agents)IBA 04/2018
1	Opiate AlkaloidsIBA 03/2018
1	Memantine (Namenda)FDA Link 01/2012